Live Breaking News & Updates on Delmar Pharma

Shares of Novocure Ltd (NASDAQ: NVCR) were trading higher by more than 3 percent early Friday morning after the company announced that Anthem Inc (NYSE: ANTM) will begin covering its Optune therapy for members.
Novocure s Optune is a portable, noninvasive device that delivers Tumor Treating. Read More.
Don t Miss Any Updates!
News Directly in Your Inbox
Subscribe to: ....

United States , British Columbia , Novocure Optune , Delmar Pharma , Jeffrey Bachasaturday , Jeffrey Bacha , John Mccain , Asaf Danziger , John Mccainfriday , Delmar Pharmaceuticals Inc , Kazia Therapeutics Ltd , Simcere Pharmaceutical Group Ltd , Novocure Ltd , Anthem Inc , Health Care , Massachusetts General Hospital , Therapeutics Ltd , Century Cures Act , Analyst Color , Light On Glioblastoma , How Its Drug Could Help , Interview With Delmar Pharmaceutical , Stock Gains , Tumor Treating , ஒன்றுபட்டது மாநிலங்களில் , பிரிட்டிஷ் கொலம்பியா ,